NumFin

West Pharmaceutical Services, Inc.

Simbolis: WST

NYSE

368.35

USD

Rinkos kaina šiandien

  • 47.6063

    P/E santykis

  • 4.2581

    PEG koeficientas

  • 26.83B

    MRK kapitalizacija

  • 0.00%

    DIV pajamingumas

West Pharmaceutical Services, Inc. (WST) Finansinės ataskaitos

Download
MetinisKetvirtinis
LinijinisLoginis
Diagramoje matote numatytuosius skaičius dinamikoje West Pharmaceutical Services, Inc. (WST). Įmonės pajamos rodo 960.931 M vidurkį, kuris yra 0.076 % gowth. Vidutinis viso laikotarpio bendrasis pelnas yra 323.508 M, kuris yra 0.087 %. Vidutinis bendrojo pelno rodiklis yra 0.328 %. Įmonės praėjusių metų veiklos grynojo pelno augimas yra 0.013 %, kuris lygus 0.215 % % vidutiniškai per visą bendrovės istoriją.,

MetinisKetvirtinis
10Y20Y30Y40Y

Balansas

Pasinerdami į West Pharmaceutical Services, Inc. fiskalinę trajektoriją, stebime vidutinį turto augimą. Įdomu tai, kad šis rodiklis yra , atspindintis tiek aukščiausias, tiek žemiausias įmonės rodiklius. Palyginus per ketvirtį, šis skaičius pakoreguojamas iki 0. Žvilgtelėjus į praėjusius metus, matyti, kad bendras turto pokytis yra 0.059. Kalbant apie trumpalaikį turtą, WST ataskaitine valiuta yra 1936.4. Didelė šio turto dalis, būtent 853.9, yra laikoma grynaisiais pinigais ir trumpalaikėmis investicijomis. Palyginus šio segmento duomenis su praėjusių metų duomenimis, matomas -0.045% pokytis. Bendrovės ilgalaikės investicijos, nors ir nėra jos pagrindinis tikslas, yra 210, jei tokių yra, ataskaitine valiuta. Tai rodo 2.489% skirtumą nuo praėjusio ataskaitinio laikotarpio, atspindintį bendrovės strateginius pokyčius. Bendrovės skolos profilis rodo, kad bendra ilgalaikė skola ataskaitine valiuta yra 157.3. Šis skaičius reiškia, kad per metus pasikeitė -0.028%. Akcininkų vertė, kurią parodo bendras akcininkų nuosavas kapitalas, vertinama pagal 2881 ataskaitine valiuta. Šio aspekto pokytis per metus yra 0.073%. Giliau panagrinėjus bendrovės finansinius duomenis, paaiškėja daugiau informacijos. Grynosios gautinos sumos vertinamos 512, atsargos - 434.7, o prestižas - 108.5, jei toks yra. Visas nematerialusis turtas, jei toks yra, vertinamas 15.1.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985

balance-sheet.row.cash-and-short-term-investments

3150.6853.9894.3762.6
615.5
439.1
337.4
235.9
203
274.6
255.3
237.5
174.3
91.8
110.2
83.1
91.5
129.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.4
17.4
27.2
5.2
3
2.7
2.2
1.6
5.1
12.7
7.4
8.5

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
7.5
12.4
0
0
0
4.3
21
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

2089.5512507.4489
385.3
319.3
288.2
253.2
200.5
181.4
179
185.7
175
147.2
126.4
138.7
128.6
136.1
110.5
107.4
75.1
114.9
66.2
61.8
60.9
74.6
64.4
60.4
69.3
67.9
57.8
43.3
41.9
42.8
41.8
44
44.1
35.4
33.4
23.3

balance-sheet.row.inventory

1745.8434.7414.8378.4
321.3
235.7
214.5
215.2
199.3
181.1
181.5
176.9
162.2
151.8
147
129.2
115.7
111.8
97.5
61.2
56.7
48
41.3
34.3
41
42.1
43.5
38.3
44
48.3
38.1
34.5
38
33.8
46.4
44.7
42.8
36.7
34.7
23.5

balance-sheet.row.other-current-assets

489.9135.8103112
51.6
64.6
54.3
39.2
39.1
36.6
35.7
34.7
38.1
73.3
42.5
38.4
25.3
29.7
21.3
17.4
17.7
9.9
15.4
17.9
28.5
22.7
20.5
19.7
16
14.8
13.6
10.2
15.8
18.1
10.8
7.1
4.5
5.1
3
1.2

balance-sheet.row.total-current-assets

7475.81936.41919.51742
1373.7
1058.7
894.4
743.5
641.9
673.7
659.3
650.7
557.3
472
436.6
397.2
366.2
412.3
281.7
237.2
226.5
216.7
161.3
158.5
173.1
184.7
159.7
170.7
156.7
148.4
136.7
93.2
98.7
97.4
101.2
97.4
96.5
89.9
78.5
56.5

balance-sheet.row.property-plant-equipment-net

5826.81512.51262.71126.8
1011.5
909.4
822
855
778.3
721
705.8
711.7
669
593.6
554.8
577.1
531
481.7
384.7
328
283.8
255.7
223.3
210.3
235.8
227.6
220.3
202.2
210.3
229.3
192.2
172.8
165.8
165.8
201.3
178.8
169
155.5
125
97.5

balance-sheet.row.goodwill

430.9108.5107.3109.9
111.1
107.8
105.8
107.7
103
104.6
108.6
114.2
112.5
111.5
112.5
114.2
105.3
109.2
102.8
89.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

61.515.118.423
30.5
29.8
20.4
21.7
23.3
37.6
42
48.3
50.6
52
55.1
55.6
50
55
66.3
159.2
43.7
48.4
44.5
32.6
52.4
66.5
61.2
51.6
58.9
63
33.9
12.7
14.1
15
17.8
14.2
12.8
12.3
9
0

balance-sheet.row.goodwill-and-intangible-assets

492.4123.6125.7132.9
141.6
137.6
126.2
129.4
126.3
142.2
150.6
162.5
163.1
163.5
167.6
169.8
155.3
164.2
169.1
159.2
43.7
48.4
44.5
32.6
52.4
66.5
61.2
51.6
58.9
63
33.9
12.7
14.1
15
17.8
14.2
12.8
12.3
9
0

balance-sheet.row.long-term-investments

810.7210204.9207.7
214.7
192.7
91.2
85.8
82.7
61.3
60.6
60.9
59.8
56.2
48.2
38.2
33.6
31.7
29.7
27.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

13125.765.648.5
16
14
24.7
25.7
66.2
70.5
66.1
61.8
90.3
85.1
64.5
69.4
63.7
61
29.8
8.3
17.9
20.5
27.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

119.421.338.455.9
36.3
29
20.5
23.4
21.3
26.4
28.5
24
24.5
28.7
22.6
19.3
18.9
34.7
23.2
63.2
86.8
82.3
80.1
109.9
96.1
73
64.4
53.4
51.5
39.4
34.6
28.7
25.8
35
23.2
22.6
20.6
22.4
24.9
25

balance-sheet.row.total-non-current-assets

7380.31893.11697.31571.8
1420.1
1282.7
1084.6
1119.3
1074.8
1021.4
1011.6
1020.9
1006.7
927.1
857.7
873.8
802.5
773.3
636.5
586.4
432.2
406.9
375.5
352.8
384.3
367.1
345.9
307.2
320.7
331.7
260.7
214.2
205.7
215.8
242.3
215.6
202.4
190.2
158.9
122.5

balance-sheet.row.other-assets

0000
0
0
-386.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

14856.13829.53616.83313.8
2793.8
2341.4
1592.4
1862.8
1716.7
1695.1
1670.9
1671.6
1564
1399.1
1294.3
1271
1168.7
1185.6
918.2
823.6
658.7
623.6
536.8
511.3
557.4
551.8
505.6
477.9
477.4
480.1
397.4
307.4
304.4
313.2
343.5
313
298.9
280.1
237.4
179

balance-sheet.row.account-payables

920.3242.4215.4232.2
213.1
156.8
130.4
138.1
122
119.8
103.1
108
102.9
89.8
63.2
68.4
67.6
80.4
61.2
46.3
29.3
29.4
19.2
22.6
27.6
25.5
20.8
18.6
23.9
22.5
19.3
14.1
20.4
16.4
18
16.3
0
0
0
0

balance-sheet.row.short-term-debt

393.2151.718.253.5
12.4
11.9
0.1
102.5
2.4
69.3
27.2
2.2
32.7
50.1
0.3
0.5
3.9
0.5
0.5
0.3
10
8
15.8
8.7
3.6
29.6
36.1
1.6
2.9
9.8
21.9
7.7
10.6
9.3
12.3
6
6.3
9.2
14.6
4.4

balance-sheet.row.tax-payables

89.53138.539.3
41.4
12.9
9.8
6
4.5
12.8
14.9
22.1
23.4
17
15
13.8
9.7
9.8
1
3.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

840.5157.3299.7271.8
313.3
317.4
196
197
226.2
228.9
309.5
371.3
378.8
299.3
358.1
379.1
382.1
394.6
235.8
280.7
150.8
167
159.2
184.3
195.8
141.5
105
87.4
95.5
104.5
35.9
24.6
31.5
49.1
66.2
52.1
48.8
51.3
29.7
26

Deferred Revenue Non Current

145.148.22.169.4
80.4
52.5
56.2
53.4
75.6
62
83.7
83.1
135.4
126
87.2
85.1
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

57.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

951.6236228.1259.7
226.9
145.4
127.7
20.5
103.4
110.8
108.9
43.3
43.5
39
42.9
41.5
34.7
61.4
1.6
78.2
0.7
81.5
52.7
18.8
48.1
48.9
47.3
37.8
38.8
29.5
45.1
25
29.9
45.2
34.4
24.7
37.2
35.5
28.3
11.9

balance-sheet.row.total-non-current-liabilities

1314.3276.7412.9384.3
435.9
426.6
298.9
303.4
358.2
356.9
461.5
528.3
573.3
501
498.9
520.8
522.5
511.8
342
361.2
241.1
247.1
247.6
259.2
272.3
215.8
170.7
141.8
159.5
164
81.9
61.6
64.8
81.2
91
77.2
84
79.6
55.6
43.2

balance-sheet.row.other-liabilities

0000
0
0
-386.5
-385.9
-370.6
-373
-377.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

405.6102.210972.3
70.5
72
0
0
0
0
0.2
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

3679.6948.5931.9978.4
939.3
768.2
196.1
197
228.6
298.2
336.7
765.2
835.1
744.2
668.6
691.9
681.6
694.7
498.9
486
357.6
366
335.3
334.5
351.6
319.8
274.9
199.8
225.1
225.8
168.2
108.4
125.7
152.1
155.7
124.2
127.5
124.3
98.5
59.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

75.218.818.818.8
18.8
18.8
18.8
18.8
18.4
18.1
17.8
17.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
4.3
4.3
4.3
4.3
4.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

138183523.42987.82456.7
1846.7
1549.4
1353.4
1178.2
1071.6
964.6
902.2
805
719.9
664.5
612.6
569.4
517.3
450.3
375.7
318.6
287.5
281.2
261.2
254
269.8
278.1
249.3
252.5
217.7
210.2
189.8
169.9
153.1
139.7
160.6
162.6
148.5
134.7
126.5
113.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-742.6-143.8-183-159.6
-110.6
-149.6
-154.2
-117.3
-186.8
-162.6
-119.2
-32.4
-75.9
-71.5
-31.3
-19.7
-44.9
33.6
10.6
8.9
33.2
18.9
-13.4
-27.4
-14.5
-5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-1974.1-517.4-138.719.5
99.6
154.6
178.3
200.2
214.3
203.8
156.1
116.2
76.3
53.3
35.8
20.8
6.1
-7.2
19.6
-2.6
-28.2
-46.8
-50.6
-54.1
-54.8
-45.9
-19.2
25.2
34.3
43.9
37.5
18.2
15.5
13
15.5
17.1
22.9
21.1
12.4
6.1

balance-sheet.row.total-stockholders-equity

11176.528812684.92335.4
1854.5
1573.2
1396.3
1279.9
1117.5
1023.9
956.9
906.4
728.9
654.9
625.7
579.1
487.1
485.3
414.5
333.5
301.1
257.6
201.5
176.8
204.8
231.2
230.1
277.7
252
254.1
227.3
188.1
168.6
152.7
176.1
179.7
171.4
155.8
138.9
119.5

balance-sheet.row.total-liabilities-and-stockholders-equity

14856.13829.53616.83313.8
2793.8
2341.4
1592.4
1476.9
1346.1
1322.1
1293.6
1671.6
1564
1399.1
1294.3
1271
1168.7
1185.6
918.2
823.6
658.7
623.6
536.8
511.3
557.4
551.8
505.6
477.9
477.4
480.1
397.4
307.4
304.4
313.2
343.5
313
298.9
280.1
237.4
179

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
5.6
4.8
4.1
0
0
0
0
1
0.8
0.6
0.4
0.3
0.2
1.9
10.9
10.1
8.4
11.7
9.1
0
0
0
0

balance-sheet.row.total-equity

11176.528812684.92335.4
1854.5
1573.2
1396.3
1279.9
1117.5
1023.9
956.9
906.4
728.9
654.9
625.7
579.1
487.1
490.9
419.3
337.6
301.1
257.6
201.5
176.8
205.8
232
230.7
278.1
252.3
254.3
229.2
199
178.7
161.1
187.8
188.8
171.4
155.8
138.9
119.5

balance-sheet.row.total-liabilities-and-total-equity

14856.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

810.7210204.9207.7
214.7
192.7
91.2
85.8
82.7
61.3
60.6
68.4
72.2
56.2
48.2
38.2
37.9
21
29.7
27.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

1233.7309317.9325.3
325.7
329.3
196.1
197
228.6
298.2
336.7
373.5
411.5
349.4
358.4
379.6
386
395.1
236.3
281
160.8
175
175
193
199.4
171.1
141.1
89
98.4
114.3
57.8
32.3
42.1
58.4
78.5
58.1
55.1
60.5
44.3
30.4

balance-sheet.row.net-debt

-1916.9-544.9-576.4-437.3
-289.8
-109.8
-141.3
-38.9
25.6
23.6
81.4
143.5
249.6
257.6
248.2
296.5
298.8
286.7
189.2
232.2
92
137.2
141.8
150.9
156.7
125.8
109.8
36.7
71
96.9
30.6
27.1
39.1
55.7
76.3
56.5
50
47.8
36.9
21.9

Pinigų srautų ataskaita

West Pharmaceutical Services, Inc. finansiniame kraštovaizdyje per pastarąjį laikotarpį pastebimas pastebimas laisvųjų pinigų srauto pokytis, rodantis -0.057 pokytį. Bendrovė neseniai išplėtė savo akcinį kapitalą išleisdama 51, o tai rodo 0.000 skirtumą, palyginti su praėjusiais metais. Bendrovės investicinė veikla lėmė grynųjų pinigų panaudojimą, kuris ataskaitine valiuta sudarė -368700000.000. Tai 0.279 pokytis, palyginti su praėjusiais metais. Tuo pačiu laikotarpiu bendrovė užregistravo 137.3, -6.7 ir -2.3, kurie yra svarbūs norint suprasti įmonės investavimo ir grąžinimo strategijas. Bendrovės finansinė veikla lėmė grynųjų pinigų panaudojimą 0.000, o per metus skirtumas buvo 0.000. Be to, bendrovė skyrė -57 dividendams akcininkams išmokėti. Kartu ji ėmėsi kitų finansinių manevrų, vadinamų -0.1, kurie taip pat turėjo didelės įtakos jos pinigų srautams šiuo laikotarpiu. Šie komponentai kartu sudaro išsamų įmonės finansinės būklės ir strateginio požiūrio į pinigų srautų valdymą vaizdą.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989

cash-flows.row.net-income

568.7593.4585.9661.8
346.2
241.7
206.9
150.7
143.6
95.6
127.1
112.3
80.7
75.5
65.3
72.6
86
70.7
67.1
45.6
19.4
31.9
18.4
19.6
1.6
38.7
6.7
44.4
16.4
28.7
27.3
22.5
19.7
-8.5
4.3
20.7

cash-flows.row.depreciation-and-amortization

141.3137.3120.6122.3
109.1
103.4
104.4
96.7
90.7
89.9
90
85.2
76.9
75.7
73.2
68.1
60.6
56.6
52.7
47.4
33.2
33
33
32
37
35.7
32.3
31.9
30.7
29.6
23.1
22
23.6
24.5
22.7
20.3

cash-flows.row.deferred-income-tax

-164.937.5-30.8-42.9
-5.8
15.3
0.9
41.7
21.5
-8.9
7
1.7
5.3
2.9
-1.8
-4.8
7.3
-6.4
4.9
2.3
-2.9
7.5
1.5
1.4
0.1
8.5
5.9
-7.5
-5.7
2
-2.7
2.5
0.6
-3.2
-2.6
-0.6

cash-flows.row.stock-based-compensation

19.823.323.737.5
34
24.4
15.1
16.1
19.5
29.6
18.6
21.2
15.5
8.4
7.8
7.5
6.4
11.8
0.9
0
10.9
0
0
-24.8
0
-9
0
-3.5
0.2
0.2
0.5
-1.4
0
26.1
-0.5
1.2

cash-flows.row.change-in-working-capital

-8.2-20.4-11.5-193.8
-10.3
-14.4
-28.3
-41.4
-58.7
-10.8
-30.6
-3.7
-3.3
-21.1
3
-15.6
-29.5
-14.5
-5.2
-20.4
1.9
12.7
-7.5
-15.1
4.9
-5.9
-0.3
2.8
-0.5
-15.7
-4.1
-6.3
-11.5
5.4
12.2
1.4

cash-flows.row.account-receivables

44-35.6-123.5
-46.6
-33.3
-43.8
-39.7
-23.3
-14.1
-6.3
-9.1
-25.7
-25.5
5.5
-6
1.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-13.5-13.5-49.8-86.5
-73.7
-18.6
-7
-3.6
-21.2
-11.4
-16.2
-13.9
-8.9
-9.3
-20.7
-6.4
-13.4
-9
-22.8
0.4
-6.9
-2.8
-4.7
-0.9
-0.5
-1.2
-2.4
2.7
-2.7
-4.5
-0.7
2.7
-4.5
10.4
3.3
-2.6

cash-flows.row.account-payables

9.54.4-2.816.8
36.6
25.3
0.4
12.6
6.1
17.2
-3.5
4.6
5.8
24.6
-0.3
-0.7
-3.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-8.2-15.376.7-0.6
73.4
12.2
22.1
-10.7
-20.3
-2.5
-4.6
14.7
25.5
-10.9
18.5
-2.5
-14.7
-5.5
17.6
-20.8
8.8
15.5
-2.8
-14.2
5.4
-4.7
2.1
0.1
2.2
-11.2
-3.4
-9
-7
-5
8.9
4

cash-flows.row.other-non-cash-items

199.35.436.1-0.9
-0.7
-3.2
-10.4
-0.5
2.8
17
-29.2
3.8
12.3
-10.7
-9.2
9.9
4.2
11
23.4
10.7
6.4
-15.9
8.5
19.6
5
1.4
26.4
-0.4
22.3
1.3
5.7
-0.8
1.6
0.1
-0.1
-0.1

cash-flows.row.net-cash-provided-by-operating-activities

756.6000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-370.5-362-284.6-253.4
-174.4
-126.4
-104.7
-130.8
-170.2
-131.6
-112.1
-155.8
-132
-96.8
-73.8
-107.8
-139.1
-129.4
-90.3
-54.1
-57.4
-60.8
-37.7
-44.1
-57.3
-63.4
-76.7
-34.4
-31.7
-31.3
-27.1
-33.5
-22.4
-25.5
-33.2
-34.3

cash-flows.row.acquisitions-net

000-2.2
0
-104
0
-6
0
0
112.1
155.8
132
96.8
-3.7
-16.9
-8.5
-4.7
0
-174.8
0
0
0
-1.1
-3.4
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
-85.1
0
0
-8.4
0
-9.3
-14.2
-31.2
-41.2
-7.2
107.8
139.1
-22.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
85.1
0
0
0
0
16.8
19.1
45.6
15.6
8.9
2.6
16.8
0.7
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-6.7-6.7-3.62.5
-5.1
2.4
3.9
3.2
2.8
2.1
-111.5
-154.8
-130.4
-94.9
1.8
-107.6
-136.5
0.2
0.2
1.5
32.9
3.7
5.4
29.8
0.2
1.7
2.9
1.4
7.2
-69.3
-10.2
8
7.5
1
1.6
-5

cash-flows.row.net-cash-used-for-investing-activites

-377.2-368.7-288.2-253.1
-179.5
-228
-100.8
-133.6
-175.8
-129.5
-104
-149.9
-116
-120.5
-74
-121.9
-128.2
-155.9
-89.9
-227.4
-24.5
-57.1
-32.3
-15.4
-60.5
-61.7
-73.8
-33
-24.5
-100.6
-37.3
-25.5
-14.9
-24.5
-31.6
-39.3

cash-flows.row.debt-repayment

-2.3-2.3-44.3-2.2
-2.3
-136.4
-0.1
-34.9
-69.8
-98.8
-285.7
-341.5
-718.4
-200.4
-40.9
-10.2
-12.3
-137.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-15.2
0
-13
-1.5

cash-flows.row.common-stock-issued

52.55128.237.1
28.8
229
0
43.9
29.7
87.3
280.5
360.1
10.9
5.8
3.7
5
6.2
4.4
4.4
14.1
13.5
3
3.3
0.7
1.5
2.8
2.6
4
3.5
2.8
3.4
3.9
5.5
1.6
0.4
1.5

cash-flows.row.common-stock-repurchased

-652-451.2-222.2-151.9
-115.5
-83.1
-75.2
-78.2
-55.9
-5.6
-4.1
-5.2
-4.7
-3.5
-2.1
-1.3
-5.2
-43
0
-0.1
-0.1
0
-0.1
-0.1
-10.8
-18.1
-60.4
0
0
0
0
0
-3.3
0
-11.3
-5.3

cash-flows.row.dividends-paid

-57.6-57-54.1-51.1
-48.1
-45.1
-42.1
-39.1
-35.8
-32.4
-29.1
-26.8
-24.9
-23.2
-21.7
-20.1
-18.6
-17.5
-15.9
-14.1
-12.8
-11.8
-11.1
-10.5
-9.8
-10.3
-9.4
-9.4
-10
-8.1
-7.2
-7
-6.3
-6.2
-6.3
-5

cash-flows.row.other-financing-activites

-1.5-0.1-1.2-14.8
-89
-1.2
36.7
-0.7
17.9
8
7.6
8.3
733.7
196.6
27
4
9
278.2
-48.7
120.6
-16
-3.3
-25.1
-5.9
30.3
34.2
48.2
-1.7
-22.4
49.2
12.5
-7.6
0.5
-14.8
25.9
3.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-659.6-459.6-293.6-168.1
-137.1
-36.8
-80.7
-109
-113.9
-41.5
-30.8
-5.1
-3.4
-24.7
-34
-22.6
-20.9
84.6
-60.2
120.5
-15.4
-12.1
-33
-15.8
11.2
8.6
-19
-7.1
-28.9
43.9
8.7
-10.7
-18.8
-19.4
-4.3
-7

cash-flows.row.effect-of-forex-changes-on-cash

-4.311.4-10.5-15.7
20.5
-0.7
-5.6
12.2
-1.3
-22.1
-22.8
2.6
2.1
-3.9
-3.2
2.7
-7.1
3.4
4.6
1.3
2
4.6
2.5
-2.1
-1.9
-2.3
0.8
-2.6
-0.1
0.8
0.8
-0.1
-19.1
-19.9
0.4
-0.1

cash-flows.row.net-change-in-cash

-953-40.4131.7147.1
176.4
101.7
101.5
32.9
-71.6
19.3
25.3
68.1
70.1
-18.4
27.1
-4.1
-21.2
61.3
-1.7
-20
31
4.6
-8.9
-0.6
-2.6
14
-21
25
9.9
-9.8
22
2.2
-18.8
-19.4
0.5
-3.5

cash-flows.row.cash-at-end-of-period

2482.1853.9894.3762.6
615.5
439.1
337.4
235.9
203
274.6
255.3
230
161.9
91.8
110.2
83.1
87.2
108.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.3
17.4
27.2
5.2
-16.1
-17.2
2.1
1.6

cash-flows.row.cash-at-beginning-of-period

3435.1894.3762.6615.5
439.1
337.4
235.9
203
274.6
255.3
230
161.9
91.8
110.2
83.1
87.2
108.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.3
17.4
27.2
5.2
3
2.7
2.2
1.6
5.1

cash-flows.row.operating-cash-flow

756.6776.5724584
472.5
367.2
288.6
263.3
219.4
212.4
182.9
220.5
187.4
130.7
138.3
137.7
135
129.2
143.8
85.6
68.9
69.2
53.9
32.7
48.6
69.4
71
67.7
63.4
46.1
49.8
38.5
34
44.4
36
42.9

cash-flows.row.capital-expenditure

-370.5-362-284.6-253.4
-174.4
-126.4
-104.7
-130.8
-170.2
-131.6
-112.1
-155.8
-132
-96.8
-73.8
-107.8
-139.1
-129.4
-90.3
-54.1
-57.4
-60.8
-37.7
-44.1
-57.3
-63.4
-76.7
-34.4
-31.7
-31.3
-27.1
-33.5
-22.4
-25.5
-33.2
-34.3

cash-flows.row.free-cash-flow

386.1414.5439.4330.6
298.1
240.8
183.9
132.5
49.2
80.8
70.8
64.7
55.4
33.9
64.5
29.9
-4.1
-0.2
53.5
31.5
11.5
8.4
16.2
-11.4
-8.7
6
-5.7
33.3
31.7
14.8
22.7
5
11.6
18.9
2.8
8.6

Pajamų ataskaitos eilutė

West Pharmaceutical Services, Inc. pajamos, palyginti su ankstesniu laikotarpiu, pasikeitė 0.022%. Pranešama, kad bendrasis WST pelnas yra 1129.2. Bendrovės veiklos sąnaudos yra 421.8, palyginti su praėjusiais metais, jos pakito 4.873%. Nusidėvėjimo ir amortizacijos sąnaudos yra 137.3, o tai yra 0.138% pokytis nuo praėjusio ataskaitinio laikotarpio. Pranešama, kad veiklos išlaidos yra 421.8, kurios rodo 4.873% pokytį per metus. Pardavimo ir rinkodaros išlaidos yra 0, kuris yra 0.000% рokytis, palyginti su praėjusiais metais. Naujausiais duomenimis pagrįsta EBITDA yra 0, o tai reiškia -0.079% augimą per metus. Veiklos pajamos yra 676, kurios rodo -0.079% pokytį, palyginti su praėjusiais metais. Grynųjų pajamų pokytis yra 0.013%. Praėjusių metų grynosios pajamos buvo 593.4.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985

income-statement-row.row.total-revenue

2928.62949.82886.92831.6
2146.9
1839.9
1717.4
1599.1
1509.1
1399.8
1421.4
1368.4
1266.4
1192.3
1104.7
1055.7
1051.1
1020.1
913.3
699.7
541.6
490.7
419.7
396.9
430.1
469.1
449.7
452.5
458.8
412.9
365.1
348.7
338.2
329.6
323.2
308.7
288.2
253.3
235.6
190.1

income-statement-row.row.cost-of-revenue

1840.51820.61750.71655.8
1379.1
1234.2
1172
1086.5
1008
944
973.6
933.7
878.7
853
786.6
752.1
748.5
728.3
651.5
507.1
385.7
334.9
302.1
280.8
289.7
289.1
282.2
288.5
302
265.1
225.9
222.1
217.8
221.4
221.5
206.7
197.4
174.4
160.2
128

income-statement-row.row.gross-profit

1088.11129.21136.21175.8
767.8
605.7
545.4
512.6
501.1
455.8
447.8
434.7
387.7
339.3
318.1
303.6
302.6
291.8
261.8
192.6
155.9
155.8
117.6
116.1
140.4
180
167.5
164
156.8
147.8
139.2
126.6
120.4
108.2
101.7
102
90.8
78.9
75.4
62.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

68.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-9.9326.87.9
12
2.4
4.8
-2
-27.7
-60.1
0.2
0.5
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

426.1421.8402.2423.5
360.9
311.6
303.2
281.7
276.6
267.1
266
272.8
251.3
221.7
213.3
197.6
191.9
168.6
160.8
121.7
106.7
94.3
81
71.9
104.7
113.6
102.8
102.1
103.5
99.5
92.1
85.5
80.7
109.5
80.5
65.9
60.4
49
44.6
38.6

income-statement-row.row.cost-and-expenses

2266.62242.42152.92079.3
1740
1545.8
1475.2
1368.2
1284.6
1211.1
1239.6
1206.5
1130
1074.7
999.9
949.7
940.4
896.9
812.3
628.8
492.4
429.2
383.1
352.7
394.4
402.7
385
390.6
405.5
364.6
318
307.6
298.5
330.9
302
272.6
257.8
223.4
204.8
166.6

income-statement-row.row.interest-income

11.8285.11
1.4
3.8
2.1
1.3
1.1
1.6
3.5
1.9
1.8
1.3
0.6
0.8
1.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

8.497.97.2
6.8
4.7
6.3
6.5
7
12.5
13
15.1
14.9
18.2
16.8
14.4
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-10.9-28.4-54.1-3.4
-5.6
-4.8
4.8
-2
-27.7
-60.1
0.2
0.3
-12.9
-8
-14.1
-4.5
-1.2
-25.8
-8.9
-15
0.9
11.3
-8.6
-0.9
-19.3
1.3
-29.5
1.6
-19.1
2.4
-1.2
0.5
-5.7
1.1
-4.3
4.1
2.6
-2.2
2.3
3.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-9.9326.87.9
12
2.4
4.8
-2
-27.7
-60.1
0.2
0.5
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-10.9-28.4-54.1-3.4
-5.6
-4.8
4.8
-2
-27.7
-60.1
0.2
0.3
-12.9
-8
-14.1
-4.5
-1.2
-25.8
-8.9
-15
0.9
11.3
-8.6
-0.9
-19.3
1.3
-29.5
1.6
-19.1
2.4
-1.2
0.5
-5.7
1.1
-4.3
4.1
2.6
-2.2
2.3
3.2

income-statement-row.row.interest-expense

8.497.97.2
6.8
4.7
6.3
6.5
7
12.5
13
15.1
14.9
18.2
16.8
14.4
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

141.3137.3120.6126.1
110.3
103.3
104.4
96.7
90.7
89.9
90
85.2
76.9
75.7
73.2
68.1
60.6
56.6
52.7
47.4
33.2
33
33
32
37
35.7
32.3
31.9
30.7
29.6
23.1
22
23.6
24.5
22.7
20.3
18.9
16.8
14.7
12

income-statement-row.row.ebitda-caps

811.6---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

643.5676734752.3
406.9
296.6
240.3
228.9
196.8
128.6
182
162.4
135.1
109.6
90.7
97.5
124.1
94.9
101
72.2
48.2
54.5
26.7
41.3
35.7
66.4
64.7
61.9
53.3
48.3
47.1
41.1
39.7
-1.3
21.2
36.1
30.4
29.9
30.8
23.5

income-statement-row.row.income-before-tax

667.5698679.9748.9
401.3
291.8
240.7
222.4
189.8
116.1
169
147.1
108.6
92.7
74.5
83.1
109.5
86.4
84.5
45.2
41.2
47
17.2
27.8
3.1
57.1
27.9
57.7
27.2
42.6
40.7
36.8
34
-3.8
10.7
33.9
27.5
23.2
30.2
25.4

income-statement-row.row.income-tax-expense

115.1122.3114.7107.2
72.5
59
41.4
80.9
54.4
26.3
47.2
40.2
32.7
23.5
13.6
13.5
23.7
17.2
24.6
-0.4
11.1
16.7
4.1
8.6
1.5
18.4
21.2
13.3
10.8
13.9
13.4
14.3
14.3
4.7
6.4
13.2
10.1
9.5
13.2
10.4

income-statement-row.row.net-income

568.7593.4585.9661.8
346.2
241.7
206.9
150.7
143.6
95.6
127.1
112.3
80.7
75.5
65.3
72.6
86
70.7
67.1
45.6
19.4
31.9
18.4
-5.2
1.6
38.7
6.7
44.4
16.4
28.7
27.3
23.5
19.7
-8.5
4.3
20.7
17.4
13.7
17
15
Panašios akcijos
Jus taip pat gali dominti:
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
12.59 CNY
SHZ
BLCO
Bausch + Lomb Corporation.
14.9 USD
NYSE
137310.KS
SD BioSensor, Inc.
10540 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
8.11 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.67 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
7741.T
HOYA Corporation.
18210 JPY
JPX
ALC.SW
Alcon Inc..
73.32 CHF
SIX
TARSONS.NS
Tarsons Products Limited.
437.6 INR
NSE

Dažnai užduodami klausimai

Kas yra West Pharmaceutical Services, Inc. (WST) bendras turtas?

West Pharmaceutical Services, Inc. (WST) bendras turtas yra 3829500000.000.

Kokios yra įmonės metinės pajamos?

Metinės pajamos yra 1427400000.000.

Kokia yra įmonės pelno marža?

Įmonės pelno marža yra 0.372.

Koks yra įmonės laisvųjų pinigų srautas?

Laisvųjų pinigų srautas yra 5.253.

Kokia yra įmonės grynojo pelno marža?

Grynojo pelno marža yra 0.194.

Kokios yra bendros įmonės pajamos?

Bendrosios pajamos yra 0.220.

Kas yra West Pharmaceutical Services, Inc. (WST) grynasis pelnas (grynosios pajamos)?

Grynasis pelnas (grynosios pajamos) yra 593400000.000.

Kokia yra bendra įmonės skola?

Bendra skola yra 309000000.000.

Koks yra veiklos sąnaudų skaičius?

Veiklos sąnaudos yra 421800000.000.

Koks yra įmonės grynųjų pinigų skaičius?

Įmonės grynieji pinigai yra 601800000.000.